Viewing Study NCT01277133


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-04-14 @ 7:17 AM
Study NCT ID: NCT01277133
Status: TERMINATED
Last Update Posted: 2016-11-02
First Post: 2011-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-06
Start Date Type: None
Primary Completion Date: 2015-10
Primary Completion Date Type: ACTUAL
Completion Date: 2015-10
Completion Date Type: ACTUAL
First Submit Date: 2011-01-13
First Submit QC Date: None
Study First Post Date: 2011-01-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-01
Last Update Post Date: 2016-11-02
Last Update Post Date Type: ESTIMATED